166 related articles for article (PubMed ID: 31823277)
1. Stability evaluation of Gd chelates for macromolecular MRI contrast agents.
Yokoyama M; Shiraishi K
MAGMA; 2020 Aug; 33(4):527-536. PubMed ID: 31823277
[TBL] [Abstract][Full Text] [Related]
2. Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.
Fu Y; Raatschen HJ; Nitecki DE; Wendland MF; Novikov V; Fournier LS; Cyran C; Rogut V; Shames DM; Brasch RC
Biomacromolecules; 2007 May; 8(5):1519-29. PubMed ID: 17402781
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vivo imaging of PEG-poly(L-lysine)-based polymeric micelle MRI contrast agents.
Shiraishi K; Kawano K; Minowa T; Maitani Y; Yokoyama M
J Control Release; 2009 May; 136(1):14-20. PubMed ID: 19331861
[TBL] [Abstract][Full Text] [Related]
4. Polyion complex micelle MRI contrast agents from poly(ethylene glycol)-b-poly(l-lysine) block copolymers having Gd-DOTA; preparations and their control of T(1)-relaxivities and blood circulation characteristics.
Shiraishi K; Kawano K; Maitani Y; Yokoyama M
J Control Release; 2010 Dec; 148(2):160-7. PubMed ID: 20804796
[TBL] [Abstract][Full Text] [Related]
5. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
Laus S; Ruloff R; Tóth E; Merbach AE
Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682
[TBL] [Abstract][Full Text] [Related]
6. Is macrocycle a synonym for kinetic inertness in Gd(III) Complexes? Effect of coordinating and noncoordinating substituents on inertness and relaxivity of Gd(III) chelates with DO3A-like ligands.
Polasek M; Caravan P
Inorg Chem; 2013 Apr; 52(7):4084-96. PubMed ID: 23517079
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
[TBL] [Abstract][Full Text] [Related]
8. Poly(l-glutamic acid) Gd(III)-DOTA conjugate with a degradable spacer for magnetic resonance imaging.
Lu ZR; Wang X; Parker DL; Goodrich KC; Buswell HR
Bioconjug Chem; 2003; 14(4):715-9. PubMed ID: 12862423
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium-containing copolymeric chelates--a new potential MR contrast agent.
Unger EC; Shen D; Wu G; Stewart L; Matsunaga TO; Trouard TP
MAGMA; 1999 Aug; 8(3):154-62. PubMed ID: 10504042
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium Complex of 1,4,7,10-Tetraazacyclododecane-1,4,7-trisacetic Acid (DO3A)-Ethoxybenzyl (EOB) Conjugate as a New Macrocyclic Hepatobiliary MRI Contrast Agent.
Baek AR; Kim HK; Park S; Lee GH; Kang HJ; Jung JC; Park JS; Ryeom HK; Kim TJ; Chang Y
J Med Chem; 2017 Jun; 60(12):4861-4868. PubMed ID: 28530407
[TBL] [Abstract][Full Text] [Related]
11. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
12. Cyclen-based Gd
Rashid HU; Martines MAU; Jorge J; de Moraes PM; Umar MN; Khan K; Rehman HU
Bioorg Med Chem; 2016 Nov; 24(22):5663-5684. PubMed ID: 27729196
[TBL] [Abstract][Full Text] [Related]
13. PEG-poly(L-lysine)-based polymeric micelle MRI contrast agent: Feasibility study of a Gd-micelle contrast agent for MR lymphography.
Akai H; Shiraishi K; Yokoyama M; Yasaka K; Nojima M; Inoue Y; Abe O; Ohtomo K; Kiryu S
J Magn Reson Imaging; 2018 Jan; 47(1):238-245. PubMed ID: 28419613
[TBL] [Abstract][Full Text] [Related]
14. Polydisulfide Gd(III) chelates as biodegradable macromolecular magnetic resonance imaging contrast agents.
Lu ZR; Mohs AM; Zong Y; Feng Y
Int J Nanomedicine; 2006; 1(1):31-40. PubMed ID: 17722260
[TBL] [Abstract][Full Text] [Related]
15. Macromolecular and dendrimer-based magnetic resonance contrast agents.
Bumb A; Brechbiel MW; Choyke P
Acta Radiol; 2010 Sep; 51(7):751-67. PubMed ID: 20590365
[TBL] [Abstract][Full Text] [Related]
16. Amide conjugates of the DO3A-N-(α-amino)propionate ligand: leads for stable, high relaxivity contrast agents for MRI?
Ferreira MF; Martins AF; Martins CI; Ferreira PM; Tóth E; Rodrigues TB; Calle D; Cerdan S; López-Larrubia P; Martins JA; Geraldes CF
Contrast Media Mol Imaging; 2013; 8(1):40-9. PubMed ID: 23109391
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model.
Cyran CC; Fu Y; Rogut V; Chaopathomkul B; Wendland MF; Shames DM; Brasch RC
Acad Radiol; 2013 Oct; 20(10):1256-63. PubMed ID: 24029057
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional mesoporous silica nanospheres with cleavable Gd(III) chelates as MRI contrast agents: synthesis, characterization, target-specificity, and renal clearance.
Vivero-Escoto JL; Taylor-Pashow KM; Huxford RC; Della Rocca J; Okoruwa C; An H; Lin W; Lin W
Small; 2011 Dec; 7(24):3519-28. PubMed ID: 22069305
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
